TherapeuticsMD, Inc. (TXMD) Gross margin 2016–2023
TherapeuticsMD, Inc. (TXMD) gross margin by fiscal year — reported gross profit divided by reported revenue.
100.0%FY2023 · since FY2016: 78.4% → 100.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | 100.0% | +2.0 pp |
| FY2022 | 98.0% | +52.5 pp |
| FY2021 | 45.5% | -29.9 pp |
| FY2020 | 75.4% | -11.9 pp |
| FY2019 | 87.2% | +4.2 pp |
| FY2018 | 83.0% | -1.3 pp |
| FY2017 | 84.3% | +5.9 pp |
| FY2016 | 78.4% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice